SAGA Diagnostics AB

SAGA announces the participation in the 6.9 million EU H2020 funded consortium grant, TIGER, together with seven other partners and led by eTheRNA immunotherapies. We shall deliver ultrasensitive #HPV diagnostics to support development of an mRNA immunotherapy platform to combat HPV-associated cancers. https://sagadiagnostics.com/saga-diagnostics-co-financed-i/ #sagasafe #ultrasensitive #liquidbiopsy #ctDNA #PrecisionOncology

SAGA Diagnostics is pleased to announce the successful #ISO17025 accreditation of its laboratory in Lund, Sweden! SAGA stands for the highest quality services and reagents. Granted by #SWEDAC, the Swedish Board for Accreditation and Conformity Assessment, ISO 17025 is an international quality management standard used to assess the competency of analytical laboratories. https://sagadiagnostics.com/saga-diagnostics-achieves-iso-/

SAGA is presenting on #ultrasensitive #liquidbiopsy March 23-24 at the virtual conference "Molecular Pathology Approach to Cancer" organized by the European Association for Cancer Research (EACR) and OECI Organisation for European Cancer Institutes. Also, visit our virtual booth and chat with us live! https://sagadiagnostics.com/saga-presenting-at-the-eacr-oe/

SAGAsafe dPCR analysis used in new study on ESR1 #mutations in #breastcancer published in JNCI Cancer Spectrum! SAGAsafe assays for the ESR1 variants E380Q, D538G, Y537S, Y537N, and Y537G were used to analyze patients that had tumor and germline DNA available. Read more about it here: https://sagadiagnostics.com/sagasafe-technology-utilized-i/

SAGA is expanding once again! We are seeking a talented #dPCR assay developer scientist! If you want to join a #fun team with great mission to usher in the future of #cancerdiagnostics, don't miss this opportunity! Located in beautiful Lund, Sweden. Applicants must have extensive lab experience with #digitalPCR. Read more and apply at https://sagadiagnostics.com/now-recruiting-molecular-diagn/... Follow the instructions from the link above to apply via email. DO NOT APPLY VIA FACEBOOK.